F2 and female reproductive organ cancer: To evaluate the relationship between HNF1B and the protein-level expression of clotting factor genes, we performed IHC on 14 gynecologic cancers with cytoplasmic clearing (10 ovarian, 3 endometrial and 1 cervical carcinoma), using an antibody specific to prothrombin [21].